0001209191-19-007238.txt : 20190205
0001209191-19-007238.hdr.sgml : 20190205
20190205134916
ACCESSION NUMBER: 0001209191-19-007238
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190201
FILED AS OF DATE: 20190205
DATE AS OF CHANGE: 20190205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Andrews William T.
CENTRAL INDEX KEY: 0001638459
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33004
FILM NUMBER: 19567256
MAIL ADDRESS:
STREET 1: ONE MAIN STREET, SUITE 800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acer Therapeutics Inc.
CENTRAL INDEX KEY: 0001069308
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320426967
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE GATEWAY CENTER (300 WASHINGTON ST.)
STREET 2: SUITE 351
CITY: NEWTON
STATE: MA
ZIP: 02458
BUSINESS PHONE: (844) 902-6100
MAIL ADDRESS:
STREET 1: ONE GATEWAY CENTER (300 WASHINGTON ST.)
STREET 2: SUITE 351
CITY: NEWTON
STATE: MA
ZIP: 02458
FORMER COMPANY:
FORMER CONFORMED NAME: Opexa Therapeutics, Inc.
DATE OF NAME CHANGE: 20060616
FORMER COMPANY:
FORMER CONFORMED NAME: PharmaFrontiers Corp.
DATE OF NAME CHANGE: 20051011
FORMER COMPANY:
FORMER CONFORMED NAME: PHARMAFRONTIERS CORP
DATE OF NAME CHANGE: 20040816
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-01
0
0001069308
Acer Therapeutics Inc.
ACER
0001638459
Andrews William T.
C/O ACER THERAPEUTICS INC.
ONE GATEWAY CTR. STE 351
NEWTON
MA
02458
0
1
0
0
Chief Medical Officer
Employee Stock Option (right to buy)
24.46
2019-02-01
4
A
0
27000
0.00
A
2029-02-01
Common Stock
27000
27000
D
The option vests and becomes exercisable over four years as follows: 25% of the shares vest on February 1, 2020, and 1/16th of the shares vest each quarter thereafter for the remaining three years.
/s/ Harry Palmin, Attorney-in-fact
2019-02-05